BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22544725)

  • 1. Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma.
    Zhang X; Lin A; Zhang JG; Bao WG; Xu DP; Ruan YY; Yan WH
    Int J Cancer; 2013 Jan; 132(1):82-9. PubMed ID: 22544725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.
    Mizukami Y; Kono K; Maruyama T; Watanabe M; Kawaguchi Y; Kamimura K; Fujii H
    Br J Cancer; 2008 Nov; 99(9):1462-7. PubMed ID: 18841157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
    Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
    Lin A; Zhang X; Zhou WJ; Ruan YY; Xu DP; Wang Q; Yan WH
    Int J Cancer; 2011 Sep; 129(6):1382-90. PubMed ID: 21128238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
    Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
    Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
    Liu Q; Hao C; Su P; Shi J
    Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesion HLA-F expression is irrelevant to prognosis for patients with gastric cancer.
    Zhang JG; Zhang X; Lin A; Yan WH
    Hum Immunol; 2013 Jul; 74(7):828-32. PubMed ID: 23542057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
    Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
    Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
    Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
    J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
    Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
    Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
    Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
    Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
    Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
    Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of HLA-G Is positively associated with Kazakh esophageal squamous cell carcinoma in Xinjiang, China.
    Hu J; Li L; Liu Y; Chen Y; Liu C; Liang W; Zhao J; Zou H; Cui X; Qi Y; Li L; Feng L
    Viral Immunol; 2013 Jun; 26(3):180-4. PubMed ID: 23772974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
    Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
    Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
    Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.